1-Minute Consult

Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?

Nolan Anderson, MD, Samuel T. Ives, MD, Michelle D. Carlson, MD and Fred Apple, PhD, DABCC
Cleveland Clinic Journal of Medicine August 2020, 87 (8) 480-482; DOI: https://doi.org/10.3949/ccjm.87a.18125

Article Information

vol. 87 no. 8 480-482
DOI 
https://doi.org/10.3949/ccjm.87a.18125
PubMed 
32737047
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online July 31, 2020.
Copyright & Usage 
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Nolan Anderson, MD
  1. Pediatric Residency Program, University of Washington, Seattle
  1. Samuel T. Ives, MD⇑
  1. Division of General Internal Medicine, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  1. Address:
    Samuel T. Ives, MD, Department of Medicine, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55414; samuel.ives{at}hcmed.org
  1. Michelle D. Carlson, MD
  1. Division of Cardiology, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  1. Fred Apple, PhD, DABCC
  1. Co-Medical Director, Clinical & Forensic Toxicology Laboratory, Hennepin Healthcare/Hennepin County Medical Center; Principal Investigator, Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute; Professor, Laboratory Medicine & Pathology, University of Minnesota

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects